Leiden
Netherlands
17
2017-11-09
The entities that hold a legal rights for patent applications filed by inventor OFFRINGA Rienk:
Rienk OFFRINGA from Leiden, NL has applied for patents for these inventions. The list has both pending applications and granted patents:
Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#2 | 2015-12-03Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#3 | 2015-01-08p53 Peptide Vaccine
#4 | 2011-01-13METHODS AND MEANS FOR THE TREATMENT OF HPV INDUCED INTRAEPITHELIAL NEOPLASIAS
#5 | 2010-10-07Method of identifying a MHC class I restricted T cell response
#6 | 2010-08-19P53 peptide vaccine
#7 | 2010-04-15USE OF A VARICELLOVIRUS TAP-INHIBITOR FOR THE INDUCTION OF TUMOR-OR VIRUS-SPECIFIC IMMUNITY AGAINST TEIPP
#8 | 2009-09-03METHODS FOR IDENTIFYING T-CELL EPITOPES ASSOCIATED WITH IMPAIRED PEPTIDE PROCESSING AND APPLICATIONS OF THE IDENTIFIED EPITOPES
#9 | 2009-07-21CD40 binding molecules and CTL peptides for treating tumors
#10 | 2009-07-14Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses
#11 | 2009-03-05Methods and means for the treatment of HPV induced intraepithelial neoplasia
#12 | 2008-09-18METHOD OF IDENTIFYING A MHC CLASS I RESTRICTED T CELL RESPONSE
#13 | 2007-12-20Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#14 | 2007-04-10Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#15 | 2007-02-01Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes
#16 | 2005-11-17Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40
#17 | 2005-06-30MUC-1 derived peptides
1028809 ⎘